Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yu. V. Terekhovskaya"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 2, Pp 135-142 (2022)
Aim. To perform the analysis of antithrombotic therapy and immediate prognosis in patients with pulmonary embolism (PE) in routine clinical practice.Materials and methods. During 13 months of follow-up (2018-2019) within the framework of the Russian
Externí odkaz:
https://doaj.org/article/d7fd1ef62a204babb4842b344d13fd47
Autor:
N. N. Nikulina, Yu. V. Terekhovskaya
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 103-108 (2019)
Pulmonary embolism (PE) is the third most common cardiovascular disease (estimated incidence in Europe and the United States is at least 250000-300000 per year), as well as one of the main causes of death. At the same time, over the past two decades,
Externí odkaz:
https://doaj.org/article/abc079326fd048b999d0bf0be9c532b1
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 49-53 (2019)
Aim. To study the nine-year dynamics of prevalence, risk factors, approaches to the treatment of arterial hypertension (AH) in the Ryazan region according to a representative sample survey, to assess the impact of risk factors and cardiovascular dise
Externí odkaz:
https://doaj.org/article/e3c099bba35d48b99565132f995f6c57
Autor:
S V Fendrikova, I V Petchina, V V Skibitsky, Yu L Begrambekova, E V Adonina, Yu V Terekhovskaya, T. A. Lelyavina, E A Smirnova, N A Karanadze, A Yu Efremushkina, Ya A Kozhedub, N N Khromov-Borisov, I A Kuular, V. Yu. Malenkova
Publikováno v:
Kardiologiia. 60:18-23
Introduction Physical exercise (PE) is a necessary part in the treatment of patients with chronic heart failure (CHF), which is stated in the European Society of Cardiology guidelines and the Russian Heart Failure Society guidelines. However, this ty